From GlobeNewswire: Nurix Therapeutics, Inc. will present the company’s achievements in 2023 and major goals for 2024 at the 42nd January 2, 2024
From GlobeNewswire: Kiniksa Pharmaceuticals, Ltd. will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024 at January 2, 2024
From GlobeNewswire: Denny’s Corporation will participate in the 2024 Annual ICR Conference, with an investor presentation on Tuesday, January 9 January 2, 2024
From NASDAQ.: Nasdaq’s IR team curated a market roundup, including the assurance that deflation is desirable rather than a concern. January 2, 2024
From GlobeNewswire: Fortinet, a global cybersecurity leader, will hold a conference call to discuss its fourth quarter and Full Year January 2, 2024
From GlobeNewswire: Check Point Software Technologies will release its financial results for Q4 and full year 2023 on February 6, January 2, 2024
From GlobeNewswire: RAPT Therapeutics, Inc. will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on January January 2, 2024
From GlobeNewswire: Cabaletta Bio, Inc. (Nasdaq: CABA) announced CEO Steven Nichtberger, M.D. will present at the J.P. Morgan Healthcare Conference January 2, 2024
From GlobeNewswire: Prime Medicine, Inc. will give a corporate overview at the 42nd Annual J.P. Morgan Healthcare Conference on January January 2, 2024
From GlobeNewswire: Cogent Biosciences announced that Andrew Robbins, CEO, will present at the J.P. Morgan Healthcare Conference on January 9, January 2, 2024
From GlobeNewswire: Freshpet, Inc. announced their participation in the 2024 ICR Conference in Orlando, FL. The executive management team will January 2, 2024
From GlobeNewswire: Provident Financial Services, Inc. will release financial results for the quarter & year ended December 31, 2023 on January 2, 2024
From Nasdaq: Asia-Pacific equity markets finished mostly lower with the exception of Australia’s ASX All Ordinaries and South Korea’s KOSPI, January 2, 2024
From GlobeNewswire: Apellis Pharmaceuticals, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 January 2, 2024
From GlobeNewswire: Kymera Therapeutics, a biopharmaceutical company, will present at the 42nd J.P. Morgan Healthcare Conference in San Francisco on January 2, 2024
From GlobeNewswire: Neumora Therapeutics, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024. The January 2, 2024
From GlobeNewswire: Zealand Pharma A/S will participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th, 2024. The January 2, 2024
From GlobeNewswire: Brookfield Infrastructure Partners will hold its fourth quarter 2023 conference call and webcast on February 1, 2024 at January 1, 2024
From GlobeNewswire: Western Forest Products Inc. will release its fourth quarter and fiscal 2023 financial and operating results on February December 29, 2023
From Nasdaq: The U.S. economy is experiencing growth momentum, but it is expected to moderate due to monetary policy tightening. December 29, 2023
From RTTNews: AutoZone, Inc. (AZO) saw first quarter net income rise to $593.5 million from $539.3 million last year, with December 29, 2023
From GlobeNewswire: Banner Corporation will report its fourth-quarter results on January 18, 2024, after the market close. A conference call December 29, 2023
From RTTNews: United Community Banks, Inc. (UCBI) anticipates a Q4 net pre-tax charge of $62 million, or $0.41 per share. December 29, 2023
From RTT News: Jabil Inc. announced the closure of its Mobility business divestment to BYD Electronic. The transaction is expected December 29, 2023
From GlobeNewswire: Arkansas bank OZK announces that it will release its fourth quarter and full year 2023 earnings on January December 29, 2023
